Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Thumb Proprioception in Trapeziometacarpal Osteoarthritis

NCT07447323 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-10-23
Last updated
2026-03-03

Condition(s) studied

Trapeziometacarpal Osteoarthritis

Investigational drug(s) / intervention(s)

Thumb Proprioception Assessment

Thumb Proprioception Assessment: This is an observational study. All participants undergo a standardized thumb proprioception assessment performed by the same assessor. Proprioception is evaluated using (1) joint position sense error at the thumb trapeziometacarpal, metacarpophalangeal, and interphalangeal joints, and (2) pinch aperture proprioception error. No therapeutic intervention is delivered; assessments are for measurement purposes only.

Study summary

This study looks at people who have osteoarthritis at the base of the thumb. It examines how well the thumb can sense its position and movement.

The study has three goals:

1. To compare these measurements between people with thumb base osteoarthritis and healthy people.
2. To find out whether this ability changes from milder to more advanced levels of osteoarthritis.
3. To explore whether this ability is related to factors such as basic personal characteristics, thumb/hand muscle strength and hand use, pain and touch sensation, and emotional factors like fear of movement, anxiety, and depression.

This is an observational study. No treatment is given. Participants complete thumb measurements and several tests/questionnaires.

Eligibility

Sex
ALL
Min age
25 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria (TMC OA group): * Voluntary participation * Radiographic Eaton-Littler stage I-IV confirmed by an orthopedic specialist * Symptom duration ≥6 months * Age 25-75 years * Pain intensity ≥4/10 on the Visual Analog Scale (VAS) during daily activities at assessment * Ability to actively perform ≥40° palmar abduction * Adequate cognitive capacity to understand and perform study procedures (for participants aged ≥65 years: Montreal Cognitive Assessment \[MoCA\] score ≥21) Inclusion Criteria (Control group): * Voluntary participation * No thumb pain * Age 25-75 years * No clinical signs of TMC OA * Negative provocation tests * Adequate cognitive capacity to understand and perform study procedures (for participants aged ≥65 years: MoCA score ≥21) Exclusion Criteria (TMC OA group): * Inability to abduct the thumb beyond 40° due to severe pain/deformity (especially advanced stage III-IV) * Acute trauma or prior surgery of the hand/wrist * Conservative treatment for hand/thumb pain in the same extremity within the previous 6 months * Current use of anti-inflammatory medication * Peripheral nerve disorders affecting proprioception (e.g., carpal tunnel syndrome, dorsal radial nerve irritation, cervical radiculopathy, double crush syndrome) * Concomitant upper-extremity musculoskeletal disorders (e.g., trigger finger, De Quervain's disease) * Generalized joint hypermobility (Beighton score ≥4) * Neuromuscular, systemic peripheral neuropathic, autoimmune, rheumatic, or infectious diseases * Active malignancy * Neurological conditions affecting pain perception * Visual impairment * Pregnancy Exclusion Criteria (Control group): -Exclusion criteria identical to the TMC OA group

Primary outcome measure(s)

  • Joint Position Sense (JPS) — Baseline (single assessment at study visit)
    Thumb JPS was assessed using a joint position reproduction test at the TMC, metacarpophalangeal (MCP), and interphalangeal (IP) joints using a standard universal goniometer. Target positions were: TMC abduction at 20°, 30°, and 40°, TMC adduction at 20° and 30°; MCP flexion at 20°; and IP flexion at 20°. Each target was tested three times. JPS performance was quantified as the angular error between the target angle and the actively reproduced angle, summarized as the mean error across the three trials (degrees), with higher values indicating poorer proprioception.
  • Pinch Aperture Proprioception — Baseline (single assessment at study visit)
    Pinch aperture proprioception was assessed using a pinch aperture reproduction test with a custom-built modified goniometer-based device with reported validity and reliability. The device included circular fingertip pads to standardize thumb-index placement. Two target apertures (15° and 30°) were tested, selected to represent functional pinch apertures for common objects, such as a large medication container (approximately 3.5 cm diameter) and a standard drinking glass (approximately 7 cm diameter), respectively. For each target, three trials were performed, and angular error was computed as the difference between target and actively reproduced aperture; the mean error across trials was used (degrees), with higher values indicating greater impairment. Bidirectional testing (30°→15° and 15°→30°) was performed as described in the protocol.

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Ankara Ankara Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07447323 on ClinicalTrials.gov ↗ ← All trials in Turkey